Literature DB >> 25605922

Endo-β-N-acetylglucosaminidase forms N-GlcNAc protein aggregates during ER-associated degradation in Ngly1-defective cells.

Chengcheng Huang1, Yoichiro Harada2, Akira Hosomi2, Yuki Masahara-Negishi2, Junichi Seino2, Haruhiko Fujihira2, Yoko Funakoshi2, Takehiro Suzuki3, Naoshi Dohmae3, Tadashi Suzuki4.   

Abstract

The cytoplasmic peptide:N-glycanase (PNGase; Ngly1 in mice) is a deglycosylating enzyme involved in the endoplasmic reticulum (ER)-associated degradation (ERAD) process. The precise role of Ngly1 in the ERAD process, however, remains unclear in mammals. The findings reported herein, using mouse embryonic fibroblast (MEF) cells, that the ablation of Ngly1 causes dysregulation of the ERAD process. Interestingly, not only delayed degradation but also the deglycosylation of a misfolded glycoprotein was observed in Ngly1(-/-) MEF cells. The unconventional deglycosylation reaction was found to be catalyzed by the cytosolic endo-β-N-acetylglucosaminidase (ENGase), generating aggregation-prone N-GlcNAc proteins. The ERAD dysregulation in cells lacking Ngly1 was restored by the additional knockout of ENGase gene. Thus, our study underscores the functional importance of Ngly1 in the ERAD process and provides a potential mechanism underlying the phenotypic consequences of a newly emerging genetic disorder caused by mutation of the human NGLY1 gene.

Entities:  

Keywords:  ENGase; ERAD; PNGase (Ngly1); glycoprotein; protein aggregates

Mesh:

Substances:

Year:  2015        PMID: 25605922      PMCID: PMC4321286          DOI: 10.1073/pnas.1414593112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Using a small molecule inhibitor of peptide: N-glycanase to probe its role in glycoprotein turnover.

Authors:  Shahram Misaghi; Michael E Pacold; Daniël Blom; Hidde L Ploegh; Gregory Alan Korbel
Journal:  Chem Biol       Date:  2004-12

2.  Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome.

Authors:  E A Hughes; C Hammond; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

3.  Cytosolic degradation of T-cell receptor alpha chains by the proteasome.

Authors:  H Yu; G Kaung; S Kobayashi; R R Kopito
Journal:  J Biol Chem       Date:  1997-08-15       Impact factor: 5.157

4.  Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells.

Authors:  R Halaban; E Cheng; Y Zhang; G Moellmann; D Hanlon; M Michalak; V Setaluri; D N Hebert
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

5.  The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol.

Authors:  E J Wiertz; T R Jones; L Sun; M Bogyo; H J Geuze; H L Ploegh
Journal:  Cell       Date:  1996-03-08       Impact factor: 41.582

6.  Ubiquitination is required for the retro-translocation of a short-lived luminal endoplasmic reticulum glycoprotein to the cytosol for degradation by the proteasome.

Authors:  M de Virgilio; H Weninger; N E Ivessa
Journal:  J Biol Chem       Date:  1998-04-17       Impact factor: 5.157

7.  The mechanism underlying cystic fibrosis transmembrane conductance regulator transport from the endoplasmic reticulum to the proteasome includes Sec61beta and a cytosolic, deglycosylated intermediary.

Authors:  Z Bebök; C Mazzochi; S A King; J S Hong; E J Sorscher
Journal:  J Biol Chem       Date:  1998-11-06       Impact factor: 5.157

8.  Identification of peptide:N-glycanase activity in mammalian-derived cultured cells.

Authors:  T Suzuki; A Seko; K Kitajima; Y Inoue; S Inoue
Journal:  Biochem Biophys Res Commun       Date:  1993-08-16       Impact factor: 3.575

9.  Purification and enzymatic properties of peptide:N-glycanase from C3H mouse-derived L-929 fibroblast cells. Possible widespread occurrence of post-translational remodification of proteins by N-deglycosylation.

Authors:  T Suzuki; A Seko; K Kitajima; Y Inoue; S Inoue
Journal:  J Biol Chem       Date:  1994-07-01       Impact factor: 5.157

10.  A glycosylated type I membrane protein becomes cytosolic when peptide: N-glycanase is compromised.

Authors:  Daniël Blom; Christian Hirsch; Patrick Stern; Domenico Tortorella; Hidde L Ploegh
Journal:  EMBO J       Date:  2004-01-29       Impact factor: 11.598

View more
  40 in total

1.  Mitochondrial function requires NGLY1.

Authors:  Jianping Kong; Min Peng; Julian Ostrovsky; Young Joon Kwon; Olga Oretsky; Elizabeth M McCormick; Miao He; Yair Argon; Marni J Falk
Journal:  Mitochondrion       Date:  2017-07-25       Impact factor: 4.160

2.  Non-lysosomal Degradation of Singly Phosphorylated Oligosaccharides Initiated by the Action of a Cytosolic Endo-β-N-acetylglucosaminidase.

Authors:  Yoichiro Harada; Chengcheng Huang; Satoshi Yamaki; Naoshi Dohmae; Tadashi Suzuki
Journal:  J Biol Chem       Date:  2016-02-08       Impact factor: 5.157

3.  Therapeutic Monosaccharides: Looking Back, Moving Forward.

Authors:  Paulina Sosicka; Bobby G Ng; Hudson H Freeze
Journal:  Biochemistry       Date:  2019-08-22       Impact factor: 3.162

4.  Repurposing of Proton Pump Inhibitors as first identified small molecule inhibitors of endo-β-N-acetylglucosaminidase (ENGase) for the treatment of NGLY1 deficiency, a rare genetic disease.

Authors:  Yiling Bi; Matthew Might; Hariprasad Vankayalapati; Balagurunathan Kuberan
Journal:  Bioorg Med Chem Lett       Date:  2017-05-05       Impact factor: 2.823

5.  Generation of a Mutant Mucor hiemalis Endoglycosidase That Acts on Core-fucosylated N-Glycans.

Authors:  Toshihiko Katoh; Takane Katayama; Yusuke Tomabechi; Yoshihide Nishikawa; Jyunichi Kumada; Yuji Matsuzaki; Kenji Yamamoto
Journal:  J Biol Chem       Date:  2016-09-14       Impact factor: 5.157

Review 6.  The cytoplasmic peptide:N-glycanase (NGLY1) - Structure, expression and cellular functions.

Authors:  Tadashi Suzuki; Chengcheng Huang; Haruhiko Fujihira
Journal:  Gene       Date:  2015-11-30       Impact factor: 3.688

Review 7.  Novel NGLY1 gene variants in Chinese children with global developmental delay, microcephaly, hypotonia, hypertransaminasemia, alacrimia, and feeding difficulty.

Authors:  Kuerbanjiang Abuduxikuer; Lin Zou; Lei Wang; Li Chen; Jian-She Wang
Journal:  J Hum Genet       Date:  2020-01-21       Impact factor: 3.172

8.  Mammalian STT3A/B oligosaccharyltransferases segregate N-glycosylation at the translocon from lipid-linked oligosaccharide hydrolysis.

Authors:  Hua Lu; Charles S Fermaintt; Natalia A Cherepanova; Reid Gilmore; Nan Yan; Mark A Lehrman
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-04       Impact factor: 11.205

9.  Transcriptome and functional analysis in a Drosophila model of NGLY1 deficiency provides insight into therapeutic approaches.

Authors:  Katie G Owings; Joshua B Lowry; Yiling Bi; Matthew Might; Clement Y Chow
Journal:  Hum Mol Genet       Date:  2018-03-15       Impact factor: 6.150

10.  Cytosolic N-GlcNAc proteins are formed by the action of endo-β-N-acetylglucosaminidase.

Authors:  Jason C Maynard; Haruhiko Fujihira; Gabby E Dolgonos; Tadashi Suzuki; Alma L Burlingame
Journal:  Biochem Biophys Res Commun       Date:  2020-08-08       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.